Adia Nutrition Announces Successful Removal of Shell Risk Designation by OTC Markets, Advancing Toward OTCQB Uplisting

Core Viewpoint - Adia Nutrition Inc. has successfully removed its shell risk designation from OTC Markets, marking a significant step towards uplisting from OTC Pink Sheets to OTCQB Venture Market, enhancing its operational integrity and investor visibility [1][2][4]. Company Overview - Adia Nutrition Inc. is focused on innovative nutritional products and regenerative medical treatments, with two main divisions: a supplement division offering premium organic supplements and a medical division specializing in advanced stem cell therapies [5]. Market Activity - The company has a market capitalization of approximately $6.71 million as of February 25, 2025, with authorized shares totaling 800 million and outstanding shares at 95.9 million [2]. - The float is reported to be 13.85 million shares, indicating a relatively low number of shares available for trading [2]. Uplisting Progress - The removal of the shell risk designation is a critical requirement for achieving OTCQB status, which is expected to provide greater transparency, liquidity, and investor trust [2][4]. - The company has been actively working with OTC Markets to meet uplisting criteria, including undergoing a comprehensive third-party audit [2]. Leadership Statement - The CEO of Adia Nutrition expressed confidence in the company's future and the potential for sharing exciting updates with investors following the removal of the shell risk designation [3].